Physician profile
Edward Gerstenfeld
NPI 1972531788
$211,381.70
in general payments reported to CMS, 2019-2025
17 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $3,646 · 2021: $32K · 2022: $16K · 2023: $65K · 2024: $36K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Grant: $39K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $10K · Food and Beverage: $6,705 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,095.00 |
| Grant | $39,320.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,787.50 |
| Travel and Lodging | $10,253.73 |
| Food and Beverage | $6,704.87 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,587.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $79,275.84 | 2019-2025 | Farapulse, General - Therapies, General - Ep |
| Adagio Medical, INC. | $39,368.71 | 2022-2023 | |
| Abbott Laboratories | $32,758.24 | 2019-2025 | Ensite Precision, Ensite, Aveir |
| Biosense Webster, INC. | $18,502.25 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medtronic Vascular, INC. | $9,191.79 | 2019-2020 | |
| Medtronic, INC. | $9,060.59 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Medical Device Business Services, INC. | $8,324.55 | 2022-2024 | Carto 3 |
| Siemens Medical Solutions USA, INC. | $5,800.00 | 2022-2025 | |
| Boehringer Ingelheim International Gmbh | $3,864.00 | 2019 | |
| Cardiofocus, INC. | $2,775.31 | 2019 | |
| Biotronik INC. | $2,149.31 | 2023 | Acticor 7 Vr-T Dx |
| Ebr Systems, INC. | $135.72 | 2025 | |
| Merck Sharp & Dohme LLC | $99.89 | 2023 | Verquvo |
| Cardiva Medical, INC. | $63.53 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $11.97 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Gerstenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.